- Home
- IBM vs ABBV Comparison
IBM vs ABBV Comparison
Compare IBM & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBM | ABBV |
|---|---|---|
| Founded | 1911 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.7B | 358.5B |
| IPO Year | 2012 | 2012 |
Fundamental Metrics
Financial Performance| Metric | IBM | ABBV |
|---|---|---|
| Price | $237.65 | $252.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 18 |
| Target Price | ★ $293.33 | $253.71 |
| AVG Volume (30 Days) | ★ 9.4M | 3.8M |
| Earning Date | 04-22-2026 | 04-29-2026 |
| Dividend Yield | 2.98% | ★ 3.39% |
| EPS Growth | ★ 73.72 | N/A |
| EPS | ★ 3.55 | 2.42 |
| Revenue | ★ $67,535,000,000.00 | $61,160,000,000.00 |
| Revenue This Year | $6.40 | $11.87 |
| Revenue Next Year | $4.60 | $8.12 |
| P/E Ratio | ★ $66.47 | $102.75 |
| Revenue Growth | 7.62 | ★ 8.57 |
| 52 Week Low | $199.19 | $190.75 |
| 52 Week High | $332.46 | $267.47 |
Technical Indicators
Market Signals| Indicator | IBM | ABBV |
|---|---|---|
| Relative Strength Index (RSI) | 49.81 | 55.40 |
| Support Level | $232.13 | $242.14 |
| Resistance Level | $259.05 | $263.35 |
| Average True Range (ATR) | 6.58 | 5.84 |
| MACD | 3.21 | -0.98 |
| Stochastic Oscillator | 82.93 | 45.55 |
Price Performance
Historical ComparisonAbout IBM International Business Machines Corporation
Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world. It provides software, IT consulting services, and hardware to help business customers modernize their technology workflows. IBM operates in 175 countries and employs approximately 300,000 people. The company has a robust roster of business partners to service its clients, which includes 95% of all Fortune 500 companies. IBM's products, including Red Hat, watsonx, and mainframes, handle some of the world's most important data workloads in areas like finance and retail.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.